SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-008661
Filing Date
2024-01-16
Accepted
2024-01-16 17:20:53
Documents
14
Period of Report
2024-01-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d726286d8k.htm   iXBRL 8-K 32998
2 EX-99.1 d726286dex991.htm EX-99.1 18171
6 GRAPHIC g726286dsp006.jpg GRAPHIC 4377
  Complete submission text file 0001193125-24-008661.txt   191672

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bior-20240116.xsd EX-101.SCH 2868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20240116_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20240116_pre.xml EX-101.PRE 11719
8 EXTRACTED XBRL INSTANCE DOCUMENT d726286d8k_htm.xml XML 3479
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 24536053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)